Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 251-260 of 271 for Lung cancer

Edit search filters
  1. Study To Evaluate The Safety, Tolerability & Efficacy Of TNG462 In Combination In PDAC & NSCLC Patients

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Transbronchial Biopsy Assisted By Robot Guidance In The Evaluation Of Tumors Of The Lung

    Scottsdale/Phoenix, AZ

  3. A Study Of Bronchoalveolar Lavage Fluid Biorepository For Biomarker Discovery In Lung Cancer

    Jacksonville, FL

  4. Survey Study On Patient Reported Outcomes For Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  5. Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

    Scottsdale/Phoenix, AZ

  6. A Study Of VENTANA TROP2 (EPR20043) Device In Non-Small Cell Lung Cancer (NSCLC)

    Rochester, MN

  7. A Study Identifying Predictive Biomarkers For The Progression Of Invasive Squamous Cell Carcinoma

    Rochester, MN

  8. A Study To Analyze Isolation, Activation And Expansion Of Mutation Reactive T-cells

    Rochester, MN

  9. Isolating And Testing Circulating Tumor DNA And Soluble Immune Markers During The Course Of Treatment For Lung Cancer

    Rochester, MN

  10. A Study To Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung And Other Cancer Types

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer